Associations Between the Modified Food Standard Agency Nutrient Profiling System Dietary Index and Cardiovascular Risk Factors in an Elderly Population.
FSAm-NPS dietary index
PREDIMED-Plus study
body weight
cardiovascular risk factor
front of pack food labeling
Journal
Frontiers in nutrition
ISSN: 2296-861X
Titre abrégé: Front Nutr
Pays: Switzerland
ID NLM: 101642264
Informations de publication
Date de publication:
2022
2022
Historique:
received:
15
03
2022
accepted:
22
06
2022
entrez:
15
8
2022
pubmed:
16
8
2022
medline:
16
8
2022
Statut:
epublish
Résumé
Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure. Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models. Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval]; This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Sections du résumé
Background
UNASSIGNED
Helping consumers to improve the nutritional quality of their diet is a key public health action to prevent cardiovascular diseases (CVDs). The modified version of the Food Standard Agency Nutrient Profiling System Dietary Index (FSAm-NPS DI) underpinning the Nutri-Score front-of-pack label has been used in public health strategies to address the deleterious consequences of poor diets. This study aimed to assess the association between the FSAm-NPS DI and some CVD risk factors including body mass index (BMI), waist circumference, plasma glucose levels, triglyceride levels, high-density lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol, and diastolic and systolic blood pressure.
Materials and Methods
UNASSIGNED
Dietary intake was assessed at baseline and after 1 year of follow-up using a 143-item validated semi-quantitative food-frequency questionnaire. Dietary indices based on FSAm-NPS applied at an individual level were computed to characterize the diet quality of 5,921 participants aged 55-75 years with overweight/obesity and metabolic syndrome from the PREDIMED-plus cohort. Associations between the FSAm-NPS DI and CVD risk factors were assessed using linear regression models.
Results
UNASSIGNED
Compared to participants with a higher nutritional quality of diet (measured by a lower FSAm-NPS DI at baseline or a decrease in FSAm-NPS DI after 1 year), those participants with a lower nutritional quality of diet (higher FSAm-NPS DI or an increase in score) showed a significant increase in the levels of plasma glucose, triglycerides, diastolic blood pressure, BMI, and waist circumference (β coefficient [95% confidence interval];
Conclusion
UNASSIGNED
This prospective cohort study suggests that the consumption of food items with a higher FSAm-NPS DI is associated with increased levels of several major risk factors for CVD including adiposity, fasting plasma glucose, triglycerides, and diastolic blood pressure. However, results must be cautiously interpreted because no significant prospective associations were identified for critical CVD risk factors, such as HDL and LDL-cholesterol, and systolic blood pressure.
Identifiants
pubmed: 35967785
doi: 10.3389/fnut.2022.897089
pmc: PMC9364822
doi:
Types de publication
Journal Article
Langues
eng
Pagination
897089Informations de copyright
Copyright © 2022 Khoury, Gómez-Donoso, Martínez, Martínez-González, Corella, Fitó, Martínez, Alonso-Gómez, Wärnberg, Vioque, Romaguera, León-Acuña, Tinahones, Santos-Lozano, Serra-Majem, Massó Guijarro, Tur, Martín Sánchez, Pintó, Delgado-Rodríguez, Matía-Martín, Vidal, Vázquez, Daimiel, Ros, Bes-Rastrollo, Barragan, Castañer, Torres-Peña, Notario-Barandiaran, Muñoz-Bravo, Abete, Prohens, Cano-Ibáñez, Tojal Sierra, Fernández-García, Sayon-Orea, Pascual, Sorli, Zomeño, Peña-Orihuela, Signes-Pastor, Basterra-Gortari, Schröeder, Salas Salvadó and Babio.
Déclaration de conflit d'intérêts
JSS served on the board of the International Nut and Dried Fruit Council and receives grant support through this institution. He also served in the Executive Committee of the Instituto Danone, Spain, and on the Scientific Committee of the Danone International Institute. He received research support from the Patrimonio Comunal Olivarero, Spain, and Borges S.A., Spain. He received consulting fees or travel expenses from Eroski Foundation, the Instituto Danone, Spain, Mundipharma and Abbot Laboratories. ER reports grants, personal fees, non-financial support, and others from California Walnut Commission and Alexion, personal fees, non-financial support, and others from Ferrer International and Danone, and personal fees from Amarin, other than the submitted study. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
BMJ Glob Health. 2019 Dec 14;4(6):e001882
pubmed: 31908864
PLoS Med. 2018 Sep 18;15(9):e1002651
pubmed: 30226842
J Nutr. 2014 Dec;144(12):2009-17
pubmed: 25411035
Int J Cardiol. 2017 May 1;234:22-27
pubmed: 28258849
BMJ. 1991 Apr 6;302(6780):819-24
pubmed: 1827353
Prev Med. 2015 Dec;81:189-94
pubmed: 26348449
J Nutr. 2015 Oct;145(10):2355-61
pubmed: 26290007
Arch Public Health. 2019 Jun 14;77:28
pubmed: 31210933
Eur Heart J. 2015 Oct 21;36(40):2696-705
pubmed: 26306399
Am J Med. 2005 Apr;118 Suppl 2:3S-8S
pubmed: 15903289
Eur Heart J. 2013 Oct;34(39):3028-34
pubmed: 24014390
N Engl J Med. 1997 Nov 20;337(21):1491-9
pubmed: 9366580
Am J Public Health. 1998 Aug;88(8):1212-5
pubmed: 9702151
BMJ. 2020 Sep 16;370:m3173
pubmed: 32938660
Public Health Nutr. 2008 Apr;11(4):371-8
pubmed: 17605841
Nutrients. 2021 Aug 13;13(8):
pubmed: 34444941
Epidemiol Health. 2014 Jul 22;36:e2014009
pubmed: 25078382
JAMA. 1996 Feb 14;275(6):447-51
pubmed: 8627965
Eur J Nutr. 2016 Aug;55(5):1901-10
pubmed: 26293977
Eur J Clin Nutr. 2011 Nov;65(11):1190-200
pubmed: 21697817
Nutrients. 2019 Aug 06;11(8):
pubmed: 31390835
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
AMIA Annu Symp Proc. 2018 Apr 16;2017:393-402
pubmed: 29854103
Am J Clin Nutr. 2021 May 8;113(5):1301-1311
pubmed: 33676367
Eur J Clin Nutr. 2002 Jan;56(1):1-14
pubmed: 11840174
Eat Weight Disord. 2022 Jun;27(5):1575-1584
pubmed: 34664216
Nutrients. 2021 Jan 19;13(1):
pubmed: 33477758
Arterioscler Thromb. 1992 Aug;12(8):911-9
pubmed: 1386252
Br J Nutr. 2021 Apr 28;125(8):902-914
pubmed: 32878658
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
Obes Rev. 2021 Mar;22(3):e13146
pubmed: 33167080
Clin Nutr. 2021 Mar;40(3):1085-1094
pubmed: 32768318
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886